Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$332K Sell
2,492
-103
-4% -$11.7K ﹤0.01% 1913
2026
Q1
$289K Buy
+2,595
New +$307K ﹤0.01% 1881
2025
Q4
Sell
-3,633
Closed -$308K 1606
2025
Q3
$308K Buy
+3,633
New +$223K ﹤0.01% 1611

Other funds holding ABVX

Integrated Wealth Concepts's ABVX Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its Abivax (ABVX) stake by 4% in Q2 2026, selling an estimated $11.7K and leaving 2,492 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

Integrated Wealth Concepts first reported a position in ABVX in Q3 2025 and has held it in 3 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Integrated Wealth Concepts held 2,492 shares of Abivax worth $332K as of Q2 2026.
  • Integrated Wealth Concepts sold 103 Abivax shares in Q2 2026, an estimated $11.7K.
  • Abivax made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1913 holding.
  • Integrated Wealth Concepts first reported a position in Abivax in Q3 2025 and has held it in 3 quarters since.
  • 303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.